Ponsegromab treatment led to sustained weight gain and GDF-15 suppression over 64 weeks in cancer-associated cachexia patients. Patients initially on placebo gained weight after switching to ...
Thank you for standing by. My name is Tina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Atai Beckley BPL-003 phase IIb open-label extension ...
The last time I spoke about Greenwich LifeSciences (GLSI), it was with respect to a Seeking Alpha article entitled "Greenwich LifeSciences: Halting Of Breast Cancer Recurrence With GLSI-100." With ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results